Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1J-tube----[1] 6 💬
2J01GB01----[1] 299 💬
3J05A F01----[1] 135 💬
4J06BA02----[1] 309 💬
5J1081----[1] 56 💬
6J695----[1] 96 💬
7J695, BSF 415977 (formerly LU415977), WAY-165772, A-796874.0----[1] 96 💬
8JADE101----[1] 66 💬
9JADE201----[1] 46 💬
10JAK 3----[1] 46 💬
11JAK 3 Ritlecitinib[1] Ritlecitinib[1] Ritlecitinib tosylate 💬 [1] JAK3 💬 [15] Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬[1] 46 💬
12JAK inhibitor----[4] 46, 50, 97, 325 💬
13JAK inhibitor(tofacitinib/upadacitinib) as advised by the rheumatologist as add on to 25 mg methotrexate[3] Methotrexate,
Tofacitinib,
Upadacitinib		[7] Methotrexate ,
Methotrexate sodium ,
Tofacitinib citrate ,
Tofacitinib ,
Upadacitinib ,
Upadacitinib tartrate ,
Upadacitinib hydrate 💬 		[6] DHFR,
DHFR2,
JAK1,
JAK2,
JAK3,
TYK2 💬 		[42] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Folate biosynthesis, Folate transport and metabolism, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, One carbon pool by folate, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
14JAK1 / JAK2 Inhibitor----[1] 46 💬
15JAK1 / JAK2 Inhibtor----[1] 46 💬
16JAKi----[1] 46 💬
17JAKi disease activity guided continuation of same dose strategy----[1] 46 💬
18JAKi dose reduction strategy----[1] 46 💬
19Jaktinib[1] Jaktinib---[2] 85, 271 💬
20Jaktinib Hydrochloride Tablets[1] Jaktinib---[2] 85, 271 💬
21Janus Kinase Inhibitor----[4] 46, 97, 110, 162 💬
22Jardiance----[2] 65, 86 💬
23JBPOS0101[1] JBPOS0101---[1] 145 💬
24JBT-101[1] Lenabasum[1] Lenabasum 💬 [1] CNR2 💬 [1] Neuroactive ligand-receptor interaction 💬[4] 49, 50, 51, 299 💬
25JBT-101 (lenabasum)[1] Lenabasum[1] Lenabasum 💬 [1] CNR2 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 299 💬
26JBT101----[1] 299 💬
27JCXH-213----[1] 63 💬
28JE049----[1] 65 💬
29Jejunal extension tube----[1] 6 💬
30Jejunal extension tube (J-tube)----[1] 6 💬
31Jevity 1.0----[1] 2 💬
32Jevity 1.5----[1] 2 💬
33JH-DSA Semi-Quant Screen and Response Score----[1] 60 💬
34JHL1101----[1] 46 💬
35Jianpixiaozhong particles and Wuse Dietotherapy----[1] 222 💬
36Jin-shui Huan-xian granule----[1] 85 💬
37Jinarc----[1] 67 💬
38JINARC - 15 MG +45 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28X15 MG + 28 X 45 MG)----[1] 67 💬
39JINARC - 15 MG - COMPRESSA - USO ORALE - BLISTER (ALU/PVC) - 28 COMPRESSE----[1] 67 💬
40JINARC - 30 MG + 60 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28 X 30 MG + 28 X 60 MG)----[1] 67 💬
41JINARC - 30 MG +90 MG - COMPRESSA - USO ORALE - BLISTER(ALU/PVC) IN CONFEZIONE A PORTAFOGLIO - 56 COMPRESSE (28 X 30 MG + 28 X 90 MG)----[1] 67 💬
42JINARC - 30 MG - COMPRESSA - USO ORALE - BLISTER (ALU/PVC) - 28 COMPRESSE----[1] 67 💬
43Jinarc - Tolvaptan tablets[1] Tolvaptan[1] Tolvaptan 💬 [1] AVPR2 💬 [4] Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
44Jinarc 15 mg tablets, Jinarc 45 mg tablets----[1] 67 💬
45Jinarc 30 mg Tablet----[1] 67 💬
46Jinarc 30 mg tablets, 90 mg tablets----[1] 67 💬
47Jinarc 30 mg tablets, Jinarc 60 mg tablets----[1] 67 💬
48Jinarc® 15mg Tablet----[1] 67 💬
49Jinarc® 30 Tablet----[1] 67 💬
50Jing Si Herbal Tea LIQUID PACKETS----[2] 46, 271 💬
51Jinshuibao----[1] 223 💬
52Jitongning tablets----[1] 271 💬
53JKB-122----[1] 95 💬
54JKB-122 in capsule or tablet form----[1] 95 💬
55JM-010----[1] 6 💬
56JM-010 group A----[1] 6 💬
57JM-010 group B----[1] 6 💬
58JM-4----[1] 13 💬
59JMKX000189----[1] 49 💬
60JMKX003142 tablets----[1] 67 💬
61JMKX003142 will be administered orally----[1] 67 💬
62JMT601 Injection----[1] 222 💬
63JNJ 38518168----[1] 46 💬
64JnJ 54767414----[1] 28 💬
65JNJ-16240159-AAC----[1] 46 💬
66JNJ-31001074----[1] 6 💬
67JNJ-38518168----[1] 46 💬
68JNJ-38518168 (10 mg)----[1] 46 💬
69JNJ-38518168 (3 mg)----[1] 46 💬
70JNJ-38518168 (30 mg)----[1] 46 💬
71JNJ-38518168 / MTX----[1] 46 💬
72JNJ-38518168 50-mg Over Encapsulated Tablet----[1] 46 💬
73JNJ-38518168-AEK - Over Encapsulated Tablet - 50 mg----[1] 46 💬
74JNJ-38518168-ZBQ----[1] 46 💬
75JNJ-38518168-ZBQ - film-coated tablet - 10 mg----[1] 46 💬
76JNJ-38518168-ZBQ - film-coated tablet - 10mg----[1] 46 💬
77JNJ-38518168-ZBQ - film-coated tablet - 3 mg----[1] 46 💬
78JNJ-38518168-ZBQ - film-coated tablet - 30 mg----[1] 46 💬
79JNJ-38518168-ZBQ - film-coated tablet - 30mg----[1] 46 💬
80JNJ-38518168-ZBQ - film-coated tablet - 3mg----[1] 46 💬
81JNJ-39039039----[1] 210 💬
82JNJ-39758979[1] JNJ-39758979---[1] 46 💬
83JNJ-39758979 (10 mg)[1] JNJ-39758979---[1] 46 💬
84JNJ-39758979 (100 mg)[1] JNJ-39758979---[1] 46 💬
85JNJ-39758979 (30 mg)[1] JNJ-39758979---[1] 46 💬
86JNJ-39758979 (300 mg)[1] JNJ-39758979---[1] 46 💬
87JNJ-39758979 / MTX[1] JNJ-39758979---[1] 46 💬
88JNJ-39758979-AAC - enteric coated tablet - 10 mg[1] JNJ-39758979---[1] 46 💬
89JNJ-39758979-AAC - enteric coated tablet - 100 mg[1] JNJ-39758979---[1] 46 💬
90JNJ-39758979-AAC - enteric coated tablet - 30 mg[1] JNJ-39758979---[1] 46 💬
91JNJ-40346527----[1] 46 💬
92JNJ-40346527-AAC----[1] 96 💬
93JNJ-40346527-AAC - capsule - 50 mg----[1] 46 💬
94JNJ-42160443----[1] 226 💬
95JNJ-54767414----[2] 28, 49 💬
96JNJ-54781532 150 mg once daily----[1] 97 💬
97JNJ-54781532 25 mg once daily----[1] 97 💬
98JNJ-54781532 75 mg once daily----[1] 97 💬
99JNJ-54781532 75 mg twice daily----[1] 97 💬
100JNJ-54781532-AAD-10 mg----[1] 97 💬
101JNJ-54781532-AAD-30 mg----[1] 97 💬
102JNJ-54781532-AAD-5 mg----[1] 97 💬
103JNJ-55920839----[1] 49 💬
104JNJ-56022473----[1] 49 💬
105JNJ-64304500----[1] 96 💬
106JNJ-64304500-AAA----[1] 96 💬
107JNJ-64841829----[1] 97 💬
108JNJ-64841842----[1] 97 💬
109JNJ-64841855----[1] 97 💬
110JNJ-64841894----[1] 97 💬
111JNJ-64841907----[1] 97 💬
112JNJ-64841920----[1] 97 💬
113JNJ-64841933----[1] 97 💬
114JNJ-64841946----[1] 97 💬
115JNJ-66525433----[1] 97 💬
116JNJ-67484703----[1] 46 💬
117JNJ-67864238----[1] 96 💬
118JNJ-67896049----[1] 86 💬
119JNJ-67896049 (ACT-293987)----[1] 86 💬
120JNJ-67896062 / ACT-064992----[2] 86, 88 💬
121JNJ-67896062/ACT-064922----[1] 86 💬
122JNJ-67896153/ACT-128800----[1] 13 💬
123JNJ-72537634----[1] 97 💬
124JNJ-77242113----[2] 37, 97 💬
125JNJ-78934804----[2] 96, 97 💬
126JNJ-79635322----[1] 28 💬
127JNJ-80202135----[5] 11, 14, 46, 49, 53 💬
128JNJ31-31001074----[1] 6 💬
129JNT-517[1] JNT-517---[1] 240 💬
130JNT-517 Suspension[1] JNT-517---[1] 240 💬
131JNT-517 Tablet[1] JNT-517---[1] 240 💬
132Joint puncture----[1] 107 💬
133Jojoba oil[1] Jojoba oil---[1] 36 💬
134Jojoba oil with broccoli sprout extract[2] Broccoli,
Jojoba oil		---[1] 36 💬
135Jorveza----[1] 98 💬
136Jorveza 0.5 mg compresse orodispersibili----[1] 98 💬
137Jorveza 0.5 mg orodispersible tablets----[1] 98 💬
138Jorveza 1 mg compresse orodispersibili----[1] 98 💬
139Jorveza 1 mg orodispersible tablets----[1] 98 💬
140JP 1730----[1] 6 💬
141JP-1730/F01----[2] 6, 17 💬
142JP-1730/F02----[2] 6, 17 💬
143JP-1730/F03----[2] 6, 17 💬
144JR-141----[1] 19 💬
145JR-141 or Idursulfase[1] Idursulfase[1] Idursulfase 💬 [1] IDS 💬 [2] Glycosaminoglycan degradation, Lysosome biogenesis 💬[1] 19 💬
146JR-171----[1] 19 💬
147JR-171 (lepunafusp alfa)[1] Lepunafusp alfa---[1] 19 💬
148JR-441----[1] 19 💬
149JR-446----[1] 19 💬
150JS002----[1] 79 💬
151JS005----[1] 271 💬
152JSP191----[2] 65, 285 💬
153JTE-051----[1] 46 💬
154JTE-162----[1] 106 💬
155JTT-251[1] JTT-251---[1] 86 💬
156Juanbi pill----[1] 46 💬
157Juvit D3----[1] 6 💬
158JV001----[1] 57 💬
159JWK007 Single intravenous infusion administration----[1] 113 💬
160JX2105----[1] 6 💬
161JY231 injection----[1] 49 💬
162JYP0061----[1] 13 💬
163Jyseleca----[2] 46, 97 💬
164Jyseleca 100 mg film-coated tablets----[1] 46 💬
165Jyseleca 100mg film-coated tablets----[1] 46 💬
166Jyseleca 200 mg film-coated tablets----[1] 46 💬
167JZP-110----[1] 6 💬
168JZP385----[1] 6 💬